Kidney cancer mortality in Spain: geographic patterns and possible hypotheses by unknown
BioMed CentralBMC Cancer
ssOpen AcceResearch article
Kidney cancer mortality in Spain: geographic patterns and possible 
hypotheses
Gonzalo López-Abente*1,2, Nuria Aragonés1,2, Beatriz Pérez-Gómez1,2, 
Rebeca Ramis1,2, Enrique Vidal1,2, Javier García-Pérez1,2, Pablo Fernández-
Navarro1,2 and Marina Pollán1,2
Address: 1Cancer and Environmental Epidemiology Area, National Centre for Epidemiology, Carlos III Institute of Health, Sinesio Delgado 6, 
28029 Madrid, Spain and 2CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
Email: Gonzalo López-Abente* - glabente@isciii.es; Nuria Aragonés - naragones@isciii.es; Beatriz Pérez-Gómez - bperez@isciii.es; 
Rebeca Ramis - rramis@isciii.es; Enrique Vidal - evidal@isciii.es; Javier García-Pérez - jgarcia@isciii.es; Pablo Fernández-
Navarro - pfernandezn@isciii.es; Marina Pollán - mpollan@isciii.es
* Corresponding author    
Abstract
Background: Since the second half of the 1990s, kidney cancer mortality has tended to stabilize
and decline in many European countries, due to the decrease in the prevalence of smokers.
Nevertheless, incidence of kidney cancer is rising across the sexes in some of these countries, a
trend which may possibly reflect the fact that improvements in diagnostic techniques are being
outweighed by the increased prevalence of some of this tumor's risk factors. This study sought to:
examine the geographic pattern of kidney cancer mortality in Spain; suggest possible hypotheses
that would help explain these patterns; and enhance existing knowledge about the large proportion
of kidney tumors whose cause remains unknown.
Methods: Smoothed municipal relative risks (RRs) for kidney cancer mortality were calculated in
men and women, using the conditional autoregressive model proposed by Besag, York and Molliè.
Maps were plotted depicting smoothed relative risk estimates, and the distribution of the posterior
probability of RR>1 by sex.
Results: Municipal maps displayed a marked geographic pattern, with excess mortality in both
sexes, mainly in towns along the Bay of Biscay, including areas of Asturias, the Basque Country and,
to a lesser extent, Cantabria. Among women, the geographic pattern was strikingly singular, not in
evidence for any other tumors, and marked by excess risk in towns situated in the Salamanca area
and Extremaduran Autonomous Region. This difference would lead one to postulate the existence
of different exposures of environmental origin in the various regions.
Conclusion: The reasons for this pattern of distribution are not clear, and it would thus be of
interest if the effect of industrial emissions on this disease could be studied. The excess mortality
observed among women in towns situated in areas with a high degree of natural radiation could
reflect the influence of exposures which derive from the geologic composition of the terrain and
then become manifest through the agency of drinking water.
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During the 1980s and 90s, kidney cancer mortality
increased throughout Europe. There was a trend towards
stabilization in subsequent years, though this was princi-
pally in western European countries, with the rates contin-
uing to be very high in the eastern European countries [1].
The incidence of these tumors follows a trend which,
though very similar to that of mortality in a good number
of countries, is not in others, where it continues to rise
across the sexes (e.g., Norway, Ireland, UK England, UK
Scotland) [1,2]. In the closing decades of the 20th century,
mortality due to this tumor registered an annual increase
in Spain of 2.9% among men and 1.4% among women
[3], and it is estimated that there were approximately
4000 new cases in 2002 [4]. The most frequent histologic
type of kidney cancer in Spain is renal cell carcinoma
(RCC) (accounting for around 80% of cases), followed by
transitional cell carcinomas of the renal pelvis, ureter and
urethra [2]. The male:female incidence ratio is 2:1, though
adjusted rates vary from 4.8–11.3 cases per 100,000 pop-
ulation in men, to 2.3–4.1 in women, depending upon
the geographic area in question [2]. It has been argued
that the growing incorporation in recent decades of new
diagnostic techniques, such as echography, computed
tomography, and magnetic resonance imaging, may have
had an influence on the observed rise in incidence [5],
though the most recent reviews conclude that the
described increase is associated with the rise in prevalence
of this tumor's risk factors [6].
Established risk factors for kidney cancer include cigarette
smoking, obesity, diabetes, and hypertension [7]. How-
ever, these factors are thought to explain only half the
incidence [5,8]. In the scientific literature other risk factors
have been proposed, such as ingestion of some drugs
(phenacetin, diuretics) [9], intake of certain dietary com-
ponents (doneness of red meat) [10], or consumption of
tea and coffee, with controversial results [7]. With respect
to alcohol consumption, most studies (with differing
designs) report no association with kidney cancer, though
some do cite evidence of a possible protective effect found
exclusively among women [11], exclusively among men
[12], or in both sexes [13].
Another possible, less studied risk factor for kidney cancer
is exposure to substances contained in drinking water,
such as products resulting from disinfection of the water
[14,15], nitrites, precursors of N-nitroso compounds
[16,17] and some radionuclides. Regarding this last expo-
sure, water from bedrock frequently contains higher con-
centrations of natural radionuclides than does water from
other sources. Bladder and kidneys receive a radiation
dose when radioactive isotopes are excreted into urine
[18]. Studies conducted in Spain [19,20] and those under-
taken in other countries [21] coincide in concluding that
there is a wide variability of content in natural radionu-
clides depending upon the nature of the terrain and the
geographic location, something that might in turn have a
bearing on the spatial patterns of this disease.
Spatial analysis of health events (spatial epidemiology) is
a discipline that, albeit still in the development phase, is
already enjoying a space of its own in the field of health
research [22,23]. Its ability to suggest and detect the pos-
sible sources of heterogeneity (generally of environmental
origin) which determine the spatial patterns of incidence
and mortality due to different diseases, imbues this tool
with great interest in the sphere of epidemiology and pub-
lic health. Its potential is, moreover, being reinforced by
the ever increasing availability of geographically-indexed
population mortality and incidence data, together with
advances in computation techniques and Geographic
Information Systems. These circumstances are favoring
the analysis of the geographical distribution of health data
with growing levels of disaggregation [24], a field that
encompasses the so-called small-area studies.
The aim of this study was to show the spatial distribution
patterns of kidney cancer in men and women, and discuss,
in the light of known risk factors, possible hypotheses that
would help explain these patterns and enhance existing
knowledge about the large proportion of kidney tumors
whose cause remains unknown.
Methods
As case source, we used individual death entries for the
period 1989–1998 corresponding to kidney cancer (Inter-
national Classification of Diseases, 9th Revision/ICD-9
code 189), broken down by town or city, nationwide.
These data were furnished by the National Statistics Insti-
tute (Instituto Nacional de Estadística – INE) for the produc-
tion of a municipal cancer mortality atlas, of which these
results form part [25].
Municipal populations, broken down by age group (18
groups) and sex, were obtained from the 1991 census and
1996 municipal roll. These years correspond to the mid-
points of the two quinquennia that comprise the study
period (1989–1993 and 1994–1998). The person-years
for each five-year period were obtained by multiplying
these populations by 5.
Standardized mortality ratios (SMR) were calculated as
the ratio of observed to expected deaths. To calculate
expected cases, the overall Spanish mortality rates for the
above two 5-year periods were multiplied by each town's
person-years, broken down by age group, sex and quin-
quennium.Page 2 of 11
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risks (RRs) were calculated using the conditional autore-
gressive model proposed by Besag, York and Molliè
(BYM). This model was introduced by Clayton and Kaldor
[26], developed by Besag, York and Molliè [27], and sub-
sequently applied in the field of ecological studies [28].
These models are based on fitting Poisson spatial models
with observed cases as the dependent variable, expected
cases as offset, and two types of random effects terms
which take the following into account: a) municipal con-
tiguity (spatial term); and b) municipal heterogeneity.
The models were fitted using Markov chain Monte Carlo
simulation methods with non-informative priors [29].
Posterior distributions of relative risk were obtained using
WinBugs [30]. The criterion of contiguity used was adja-
cency of municipal boundaries. Convergence of the simu-
lations was verified using the BOA (Bayesian Output
Analysis) R program library [31]. Given the great number
of parameters of the models, the convergence analysis was
performed on a randomly selected sample of 10 towns
and cities, taking 4 strata defined by municipal size. Con-
vergence of the estimators was achieved before 100,000
iterations. For the maps shown, a "burn-in" (iterations
discarded to ensure convergence) of 300,000 iterations
was performed and the posterior distribution was derived
with 5,000.
A Geographic Information System was used to plot
municipal maps that depicted smoothed RR estimates and
the distribution of the posterior probability (pp) that
RR>1 (Bayesian version of p value). With regard to this
indicator, we followed Richardson's criterion [32], which
recommends that probabilities above 0.8 should be
deemed significant. Separate analyses were performed for
men and women.
Results
From 1989 to 1998, a total of 14116 kidney cancer deaths
were registered in Spain, 9431 among men and 4685
among women. In 5220 towns and cities no death due to
this cause was registered. Using these data and conven-
tional computers, it was possible to compile and ascertain
the posterior distribution of relative risk on the basis of a
single spatial model that included all of Spain's 8077
towns and cities and the 46398 adjacencies existing
between them.
To give an overall picture, Figure 1 depicts kidney cancer
mortality by province for both sexes. There were only six
provinces with SMRs greater than 1.15, namely, Alava,
Guipuzcoa, Biscay, Navarre, Asturias and Badajoz. The
lowest SMRs were registered in Galicia, Aragon, the Valen-
cian Region, Murcian Region and Mediterranean prov-
inces of Andalusia. Table 1 shows the results for observed
and expected deaths by province, in order to be able to
assess the magnitude of the relative risk and differences by
sex.
Figures 2 and 3 depict the distribution of: a) the smoothed
RRs for kidney cancer in men and women; and, b) the
posterior probability (pp) that RR>1. This second map
"filters" the previous one, flagging the areas in which
excess mortality is more likely.
As the patterns for each sex displayed notable similarities
and differences [25], the respective results are shown sep-
arately. The maps show that the highest mortality in both
sexes was concentrated in towns along the Bay of Biscay
coastline of the Asturian, Cantabrian and Basque Country
Autonomous Regions. The different mortality pattern reg-
istered by women was noteworthy, with excess risk in the
west of the country, covering wide swathes of Salamanca
and Extremadura. In men, the only excess mortality
observed in this area exclusively affected two towns, i.e.,
Badajoz and Mérida.
Discussion
Municipal maps of kidney cancer distribution display a
marked geographic pattern, with excess mortality in both
sexes chiefly in towns along the Bay of Biscay, including
areas of Asturias, the Basque Country and, to a lesser
extent, Cantabria. Among women, special mention must
be made of the existence of a strikingly singular pattern,
not in evidence for any other tumors and marked by
excess risk in towns situated in the Salamanca area and
Extremaduran Autonomous Region. This difference
would lead one to postulate the existence of different
exposures of environmental origin in the various regions.
Possible misclassification errors involved in the study of
RCC mortality render a high degree of caution necessary
when it comes to assessing the patterns observed in the
results. Despite the fact that undercertification of renal
cancers has been reported by studies on the accuracy of
death certification in Spain [33], there are not too many
arguments that would support possible inconsistencies
and differences of criteria in the coding of death certifi-
cates, i.e., if the certification/coding of deaths were not
correct, the errors would not necessarily follow any pat-
tern, and there would be no agreement between incidence
and mortality data. Another explanations for possible dif-
ferences in kidney cancer mortality across the country, as
differences in survival rates due to the distribution of
tumor stage at diagnosis are difficult to maintain because
the universal accessibility to the health care system. Bear-
ing in mind the characteristics of the Spanish National
Health Care System, we would have no reason to suspect
that there might be differential access to health care and
diagnosis between regions.Page 3 of 11
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TOTAL MEN WOMEN
Province obs exp SMR obs exp SMR p-val obs exp SMR p-val
ALMERIA 108 147.4 0.733 81 100.2 0.809 0.972 27 47.3 0.571 0.999
CADIZ 301 284.7 1.057 201 191.1 1.052 0.224 100 93.6 1.069 0.234
CORDOBA 266 265.6 1.002 183 176.7 1.036 0.301 83 88.9 0.933 0.713
GRANADA 236 262.2 0.900 144 177.3 0.812 0.994 92 84.9 1.084 0.203
HUELVA 131 147.9 0.886 87 98.2 0.886 0.861 44 49.7 0.885 0.768
JAEN 194 230.9 0.840 134 157.4 0.851 0.969 60 73.5 0.816 0.939
MALAGA 331 363.5 0.911 210 245 0.857 0.988 121 118.4 1.022 0.384
SEVILLE 506 483.9 1.046 330 319.5 1.033 0.268 176 164.4 1.071 0.172
HUESCA 80 107.1 0.747 49 75.1 0.652 0.999 31 32 0.970 0.520
TERUEL 66 79 0.835 39 54.8 0.712 0.984 27 24.2 1.114 0.248
ZARAGOZA 338 351.7 0.961 235 236.1 0.995 0.512 103 115.5 0.892 0.869
ASTURIAS 640 463.8 1.38 447 304.8 1.466 < 0.001 193 158.9 1.214 0.004
BALEARIC ISLES 240 263.1 0.912 169 177.1 0.954 0.713 71 86 0.825 0.945
LAS PALMAS 184 199.3 0.923 133 136.9 0.971 0.610 51 62.4 0.818 0.919
SANTA CRUZ 135 215.7 0.626 93 146.5 0.635 1 42 69.3 0.606 1
CANTABRIA 234 206.7 1.132 163 136.5 1.194 0.012 71 70.2 1.011 0.431
ALBACETE 85 132.3 0.642 54 91.2 0.592 1 31 41.1 0.755 0.937
CIUDAD REAL 174 189.9 0.916 104 127.6 0.815 0.982 70 62.3 1.124 0.149
CUENCA 72 103.1 0.698 43 71.4 0.602 1 29 31.7 0.916 0.640
GUADALAJARA 66 72.8 0.907 46 50.9 0.904 0.725 20 21.9 0.912 0.608
TOLEDO 223 209.7 1.063 150 143.6 1.044 0.281 73 66.1 1.104 0.180
AVILA 76 89.1 0.853 54 61.7 0.876 0.819 22 27.4 0.802 0.826
BURGOS 163 154.4 1.056 114 105.1 1.084 0.180 49 49.3 0.995 0.477
LEON 230 237.6 0.968 137 160.8 0.852 0.969 93 76.8 1.210 0.032
PALENCIA 76 82.2 0.924 55 54.8 1.003 0.454 21 27.4 0.767 0.872
SALAMANCA 165 166.4 0.992 100 112.3 0.891 0.867 65 54.1 1.200 0.065
SEGOVIA 56 71.9 0.779 39 49.1 0.795 0.918 17 22.8 0.747 0.868
SORIA 52 53.3 0.976 37 36.5 1.015 0.422 15 16.8 0.891 0.613
VALLADOLID 197 176 1.119 128 118.3 1.082 0.174 69 57.7 1.197 0.063
ZAMORA 93 114.5 0.812 60 77.8 0.771 0.978 33 36.7 0.898 0.697
BARCELONA 1710 1669 1.025 1125 1098.6 1.024 0.208 585 570.4 1.026 0.262
GERONA 211 204 1.034 140 138.9 1.008 0.440 71 65.1 1.091 0.212
LERIDA 125 163.5 0.765 83 113.8 0.729 0.998 42 49.7 0.845 0.847
TARRAGONA 212 219.5 0.966 145 150.1 0.966 0.641 67 69.4 0.965 0.583
ALICANTE 401 459.8 0.872 283 313.3 0.903 0.956 118 146.4 0.806 0.991
CASTELLON 164 181.8 0.902 110 124.1 0.886 0.890 54 57.8 0.935 0.659
VALENCIA 676 749.8 0.902 462 500.8 0.923 0.958 214 249.1 0.859 0.987
BADAJOZ 286 242.2 1.181 179 161.6 1.108 0.081 107 80.6 1.327 0.002
CACERES 181 169.6 1.067 110 114 0.965 0.622 71 55.6 1.277 0.020
CORUNNA 377 426.9 0.883 243 278.1 0.874 0.983 134 148.8 0.900 0.881
LUGO 132 207.4 0.637 80 141.3 0.566 1 52 66 0.787 0.956
ORENSE 130 191.1 0.68 75 127.6 0.588 1 55 63.5 0.866 0.842
PONTEVEDRA 274 311.6 0.879 179 199.9 0.895 0.927 95 111.7 0.851 0.940
MADRID 1788 1588.3 1.126 1234 1035.2 1.192 < 0.001 554 553.1 1.002 0.474
MURCIA 266 338.6 0.786 185 229 0.808 0.998 81 109.6 0.739 0.997Page 4 of 11
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certified Spanish population cancer registers and pub-
lished in "Cancer Incidence in Five Continents, Volume
IX" [2], the coincidence with mortality patterns can be
appreciated. The highest incidence rates for both sexes
were those registered in the Basque Country and Asturian
Autonomous Communities (1998–2001), there being no
data for the Provinces of Salamanca, Cáceres and Badajoz,
as population-registry-based information is still lacking in
these areas.
Smoking habit is the most widely established risk factor
for both histologic types of kidney cancer [34]. Yet, the
patterns shown in the maps presented here diverge con-
siderably from the patterns described for lung and bladder
cancer among men and women, respectively [35]. Neither
is there any concordance between the geographic pattern
NAVARRE 249 209.8 1.187 170 138.8 1.225 0.005 79 71 1.112 0.157
ALAVA 123 91.4 1.345 82 62.3 1.316 0.007 41 29.1 1.408 0.014
GUIPUZCOA 360 238.5 1.509 227 157.3 1.443 < 0.001 133 81.2 1.637 < 0.001
VIZCAYA 563 406.6 1.385 386 269.7 1.431 < 0.001 177 136.9 1.293 < 0.001
LA RIOJA 121 111.2 1.088 87 75.6 1.151 0.088 34 35.6 0.955 0.563
CEUTA 32 17.3 1.847 19 11.6 1.642 0.015 13 5.7 2.262 0.002
MELILLA 17 13.8 1.23 8 9.1 0.875 0.564 9 4.7 1.926 0.021
Observed and expected cases, SMRs and p-values shown for both sexes, men and women. Provinces grouped by autonomous region.
SMR: Standardised mortality ratio
Table 1: Kidney cancer mortality by province: Spain, 1989–1998. (Continued)
Provincial distribution of kidney cancer mortality: Spain, 1989–1998Figure 1


































































































	Page 5 of 11
(page number not for citation purposes)
BMC Cancer 2008, 8:293 http://www.biomedcentral.com/1471-2407/8/293
Page 6 of 11
(page number not for citation purposes)
Municipal distribution of kidney cancer mortality in men: Spain, 1989–1998Figure 2
Municipal distribution of kidney cancer mortality in men: Spain, 1989–1998. Distribution pattern of the smoothed 
relative risk under the BYM model and posterior probability of RR being greater than 1.
Renal cancer.  Men 1989-1998
Posterior Probability RR>1
0.9 - 1   (118)
0.8 -   (192)
0.2 -   (4902)
0.1 -   (1830)
0  -   (1150)
Renal cancer.  Men 1989-1998
Smoothed RR
>= 1.50   (28)
1.30 -   (135)
1.10 -   (624)
1.05 -   (438)
0.95 -   (1807)
0.91 -   (1013)
0.77 -   (3202)
0.67 -   (672)
< 0.67   (273)
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Municipal distribution of kidney cancer mortality in women: Spain, 1989–1998Figure 3
Municipal distribution of kidney cancer mortality in women: Spain, 1989–1998. Distribution pattern of the 
smoothed relative risk under the BYM model and posterior probability of RR being greater than 1.
Renal cancer. Women 1989-1998
Posterior Probability RR>1
0.9 - 1   (131)
0.8 -   (506)
0.2 -   (6425)
0.1 -   (675)
0  -   (455)
Renal cancer. Women 1989-1998
Smoothed RR.
>= 1.50   (10)
1.30 -   (81)
1.10 -   (1702)
1.05 -   (960)
0.95 -   (1950)
0.91 -   (1421)
0.77 -   (1853)
0.67 -   (35)
< 0.67   (180)
BMC Cancer 2008, 8:293 http://www.biomedcentral.com/1471-2407/8/293observed and the prevalence of obesity. Specifically, inso-
far as prevalence of obesity among women aged 35–64
years is concerned, only one of the provinces with excess
risk, Badajoz, figures among the 10 provinces with highest
prevalences of obesity [36].
Areas with excess kidney cancer mortality along the coast
of the Bay of Biscay also register higher mortality due to
other smoking-related tumors, among men in particular.
As has been remarked above, however, the pattern of kid-
ney cancer mortality is not concordant with that observed
for other causes of death strongly related with tobacco
[25]. Similarly, excess mortality due to ischemic heart or
cerebrovascular diseases is not observed along the coast of
the Bay of Biscay, so that other risk factors described (cig-
arette smoking, obesity, diabetes, and hypertension)[7]
would not appear to explain this pattern. Attention
should be drawn to the fact that excess kidney cancer on
the Bay of Biscay is located in a heavily industrialized area
(mining and heavy metal industry). As shown in the Euro-
pean Pollutant Emission Register (EPER), this area
receives the highest industrial cadmium, arsenic, nickel
and benzene emissions in Spain [37], substances which
are classified in IARC group 1 in terms of their carcino-
genic activity (human carcinogens) [38] and for which an
association with renal cancer has been documented [39-
43]. Nonetheless, no references could be found in the lit-
erature which analyze the possible influence of industrial
pollution on RCC.
The pattern displayed by female mortality in western parts
of central mainland Spain (Salamanca, Cáceres, and Bada-
joz) is somewhat fuzzy, with smoothed RRs not exceeding
1.3, and posterior probabilities of RR>1 exceeding 0.80
over wide areas and reaching 0.90 in very few towns,
something that could be interpreted as a consequence of
the smoothing procedure. However, this possible artifact
should affect other areas, and yet it would not appear to
do so.
Taking the late introduction of the smoking habit among
Spanish women into account [36], the peculiarities of the
pattern displayed in women can be assumed to be attrib-
utable to other factors (dietary or environmental).
Reviewing the known risk factors and possible explana-
tions for the higher risk of this disease among women in
the province of Salamanca and Extremadura, there are
very few environmental components: 1) to which women
might be more exposed; and 2) for which the kidney
might be the target organ. Given the geologic composition
of the terrain in these provinces [44,45], consumption of
drinking water is one of the possibilities that could fit
such a scenario. As men consume more alcohol than
women, their liquid intake can be surmised to involve a
lower consumption of publicly supplied water, water that
may contain components which, in the context of chronic
exposure, could well cause some form of renal toxicity. It
has been shown that chronic ingestion of certain radionu-
clides (uranium) in drinking water may affect renal func-
tion [46]. Due to the lower prevalence of smokers among
women, the effect of environmental factors might be
more visible among them, since the presence of a risk fac-
tor such as tobacco, with a far higher RR, would partially
mask the influence of environmental factors whose effect
magnitude was substantially lower.
Salamanca, Cáceres and Badajoz are all provinces rich in
uranium ore, and in one of them concentrations of radio-
nuclides (U, Th, Ra) in groundwater (bedrock) have been
found which were 5–30 times higher than in surface
water, whereas one third of the samples contained Ra con-
centrations that exceeded the recommended limits [45].
In this respect, it must be said that the percentage of the
population relying on a groundwater supply is 23% in
Castile-León and 33% in Extremadura [47].
On the other hand, there is evidence of the existence of
other granitic areas in Galicia, where natural radiation is
high [44] and yet no excess risk of kidney cancer has been
observed. The radiologic situation of this area's drinking
water is not known because no systematic studies have
been undertaken [48]. In this Autonomous Region the
percentage of the population supplied with groundwater
is 12%, a figure very much lower than that for Spain as a
whole [47]. Due to their chalky soils and highly mineral-
ized waters, the areas in Spain that register the maximum
consumption of bottled water are the Balearic Isles, Cata-
lonia, the Valencian Region, Castile-La Mancha, Murcia,
and Aragon [49], and these same areas are shown in the
maps as having lower-than-expected kidney cancer mor-
tality.
A growing number of cohort studies have reported that
alcohol consumption has a protective effect as against risk
of RCC: in men [50]; in women [12,51]; or in both [52].
The mechanism of action whereby alcohol serves to
reduce RCC risk has not been elucidated. Some authors
are of the opinion that it may be the ethanol itself that
produces the protective effect, since the effect is not con-
fined to any one type of alcoholic beverage. In the studies
consulted, no estimate is made of the effect of the reduc-
tion in daily water intake attributable to consumption of
alcoholic beverages. Mean daily intake of water in Spain is
1,574.4 ml (+- 327) among adults (aged over 17 years)
[53]. Regardless of the fact that moderate consumption of
alcohol has a slightly protective effect vis-à-vis RCC [54],
persons who received an important part of their liquid
intake in the form of alcoholic beverages (e.g., wine or
beer) would be far less exposed to agents conveyed inPage 8 of 11
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underground sources.
The nationwide survey on diet and eating habits points to
estimated alcohol consumption as being very much
higher in men. The prevalence of male alcohol consumers
in these provinces is extremely high (72% and 74% male
vs. 38% and 47% female alcohol consumers in Extrema-
dura and Castile-Leon, respectively) [36].
Exposure to products resulting from the disinfection of
water is also being targeted for study in connection with
urinary bladder tumors [55,56], though ecologic mortal-
ity [14] and experimental animal research studies suggest
a possible relationship with renal tumors [57,58].
Other compounds related with the water supply are
nitrates. Nitrate has steadily accumulated in our water
supply and is the most common chemical contaminant in
the world's groundwater aquifers [17]. In agricultural
regions, nitrate inputs are largely due to nitrogen fertilizer
use [59]. Nitrates are a precursor in the formation of N-
nitroso compounds (NOC), most of which are animal
carcinogens [60]. Specific NOC cause renal cancers in ani-
mal studies [61]. Other sources of NOC exposure include
preformed NOC found in preserved meats and fish,
tobacco, and certain occupational exposures [62].
Nitrate contamination of groundwater in Spain seriously
affects (> 50 mg/l) the entire Mediterranean seaboard,
which displays no excess risks of kidney cancer in either
sex. Among the most affected inland areas are the Man-
chegan plain, the Ebro delta and some sections of the
Guadalquivir valley. Locally, the presence of nitrates
affects different areas of the Duero (central Duero, Esla-
Valderaduey, and Arenales), Tagus (La Alcarria, Tiétar and
Ocaña), Sur (Campo de Níjar, Dalías, and Fuente Piedra),
and Segura river basins (Campo de Cartagena, Guad-
alentín, and Vegas del Segura). At a lower degree of inten-
sity (25 through 50 mg/l), this contamination affects
many water supply points across Asturias and the Basque
Country [63].
Conclusion
Municipal kidney cancer distribution maps display a
marked geographic pattern. The maps show that highest
mortality in both sexes is concentrated in towns along the
Bay of Biscay, covering areas of Asturias, the Basque
Autonomous Region and, to a lesser extent, Cantabria.
The reasons for this pattern of distribution are not at all
clear, and it would thus be of interest to study the effect of
industrial emissions and immissions on this disease.
Interventions targeted at decreasing prevalence of smok-
ing, obesity and, perhaps, hypertension might tend to sta-
bilize or reduce the incidence and mortality, and only go
some way towards mitigating the geographic differences
displayed. The different pattern registered by female mor-
tality in towns in the Salamanca area and the Extrema-
duran Autonomous Region is noteworthy but, subject in
all cases to the necessary caution, this could in part be
explained by exposures linked to the geologic composi-
tion of the terrain and, in turn, to the local drinking water.
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